Swipe om te navigeren naar een ander artikel
Department of Cardiology, Amphia Hospital, location Molengracht, Breda, the Netherlands
T.A. Simmers Department of Cardiology, Amphia Hospital, location Molengracht, PO Box 90158, 4800 RK Breda, the Netherlands
Pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF) appears to be here to stay. In just a few years since the landmark publications by Haissaguerre and Pappone, countless variations on the theme of ostial or antral PVI, with or without additional lines or point lesions, have been published. The procedure has found its way into daily practice and international guidelines, and is currently the most performed ablation in the Netherlands.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Tan ES, Mulder BA, Rienstra M, Wiesfeld ACP, Ahmed S, Zijlstra F, et al. Pulmonary vein isolation of symptomatic refractory paroxysmal and persistent atrial fibrillation: A single centre and single operator experience in the Netherlands. Neth Heart J. 2009; 17: 336–72.
Berruezo A, Tomborero D, Mont L, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein isolation. Eur Heart J. 2007; 28: 836–41.
Themistoclakis S, Schweikert RA, Saliba WI, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. H Heart Rhythm. 2008; 5: 679–85.
Beukema WP, Sie HT, Ramdat Misier AR, et al. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure. Eur J Cardiothorac Surg. 2008; 34: 771–5.
Chen MC, Chang JP, Cahng HW. Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery. Chest. 2004; 125: 2129–34.
Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation versus antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. JAMA. 2005; 293: 2634–40.
Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation. The A4 study. Circulation. 2008; 118: 2498–505.
Rajappan K, Kistler PM, Earley MJ, et al. Acute and chronic pulmonary vein reconnection after atrial fibrillation ablation: a prospective characterization of anatomic sites. Pacing Clin Electrophysiol. 2008; 31: 1598–605.
Peters DC, Wylie JV, Hauser TH, et al. Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging. 2009; 2: 308–16.
McGann CJ, Kholmovski EG, Oakes RS, et al. New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol. 2008; 52: 1263–71.
Wang XH, Liu X, Sun YM, et al. Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation. Europace. 2007; 9: 481–6.
Ouyang F, Bänsch D, Ernst S, et al. Complete isolation of left atrium surrounding the pulmonary veins. New insights from the double-lasso technique in paroxysmal atrial fibrillation. Circulation. 2004; 110: 2090–6.
Senatore G, Stabile G, Bertaglia E, et al. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2005; 45: 873–6.
Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005; 112: 307–13.
- Pulmonary vein isolation: do all roads lead to Rome?
T. A. Simmers
- Bohn Stafleu van Loghum